[AstraZeneca's "breast cancer ADC miracle drug" DS-8201 entered the new version of the medical insurance directory] According to the 2024 national medical insurance directory released today, the reporter found that the "breast cancer miracle drug" DS8201 Detriazumab for injection, which AstraZeneca was responsible for negotiations, appeared on the list of the directory. Previously, the drug failed to enter the 2023 medical insurance catalog after being included in the formal review list in 2023.